Scientists make receptor discoveries that pave the way for new drugs to treat metabolic diseases

New structural information obtained with the help of intense X-rays generated by Diamond Light Source, the UK’s synchrotron science facility in Oxfordshire, has enabled scientists from Heptares Therapeutics (“Heptares”, the UK-based subsidiary of Sosei Group Corporation) to solve the high-resolution X-ray crystal structure of the glucagon receptor. This biological receptor plays a crucial role in the management of blood glucose levels and is considered to be an important target for drugs designed to treat metabolic diseases, such as diabetes.

Aggregated News

Aggregated news from around the world, brought to you in a single source for convenience. These snippets of news include a link to the full article. Please peruse our other editorial and original content, as well.